Market Cap

BerGenBio ASA Market Capitalization:

kr447.9 Million

NOK as of July 1, 2024

US$42.0 Million

business BerGenBio ASA Company Profile

BerGenBio ASA Main Stock Listing

OSE: BGBIO

Market Capitalization History of BerGenBio ASA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of BerGenBio ASA market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr887.3 M 39.57%
Jan. 1, 2023 kr635.7 M -61.46%
Jan. 1, 2022 kr1.65 B -44.66%
Jan. 1, 2021 kr2.98 B 77.06%
Jan. 1, 2020 kr1.68 B -25.20%
Jan. 1, 2019 kr2.25 B -33.85%
Jan. 1, 2018 kr3.40 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

BerGenBio ASA Categories

languages Healthcare languages Biotechnology

Stocks & Indices

BerGenBio ASA has the following listings and related stock indices.


Stock: OSE: BGBIO

Stock: FSX: 7BG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.